Our company provides business reports and audit reports in accordance with Article 31, Paragraph 4, Item 4 of the Enforcement Decree of the Commercial Act.
This information is posted on our website for shareholders and investors.

※ The business reports and audit reports posted on the website are subject to approval at the 46th regular general meeting of shareholders.
If it is rejected or revised at future general shareholders' meetings, the contents will be reflected through corrections.

March 21, 2022
KyungDong Pharm Co., Ltd.